Diabetes and Weight-Loss Medications May Reduce Colon Cancer Risks, New Study Suggests
Recent research from Case Western Reserve School of Medicine in Cleveland hints at potential benefits beyond diabetes management and weight loss for widely used medications like Ozempic, Wegovy, Mounjaro, and Zepbound. These drugs, falling under the category of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), could also lower the risk of colon cancer, according to the … Read more